Term
|
Definition
Asthma/COPD; Short-Acting β2-adrenergic receptor agonists (Also Oral) |
|
|
Term
|
Definition
Asthma/COPD; Short-Acting β2-adrenergic receptor agonists |
|
|
Term
|
Definition
Asthma/COPD; Short-Acting β2-adrenergic receptor agonists (Also Oral) |
|
|
Term
|
Definition
Asthma/COPD; Short-Acting β2-adrenergic receptor agonists (Also Oral) |
|
|
Term
|
Definition
Asthma/COPD; Short-Acting β2-adrenergic receptor agonists |
|
|
Term
|
Definition
Asthma/COPD; Long-Acting β2-adrenergic receptor agonists |
|
|
Term
|
Definition
Asthma/COPD; Long-Acting β2-adrenergic receptor agonists |
|
|
Term
|
Definition
Asthma/COPD; Long-Acting β2-adrenergic receptor agonists |
|
|
Term
Beclomethasone Diproprionate |
|
Definition
Asthma/COPD; Inhaled Glucocorticoid |
|
|
Term
|
Definition
Asthma/COPD; Inhaled Glucocorticoid |
|
|
Term
|
Definition
Asthma/COPD; Inhaled Glucocorticoid |
|
|
Term
|
Definition
Asthma/COPD; Inhaled Glucocorticoid |
|
|
Term
|
Definition
Asthma/COPD; Inhaled Glucocorticoid |
|
|
Term
|
Definition
Asthma/COPD; Inhaled Glucocorticoid |
|
|
Term
|
Definition
Asthma/COPD; Leukotriene Receptor (Cys-LT1) Blocker; Competitive |
|
|
Term
|
Definition
Asthma/COPD and Allergic Rhinitis; Leukotriene Receptor (Cys-LT1) Blocker; Competitive |
|
|
Term
|
Definition
Asthma/COPD; Leukotriene Synthesis Inhibitor (Blocks 5-Lipoxygenase) |
|
|
Term
|
Definition
Mild/Moderate Asthma; Allergic Rhinitis |
|
|
Term
|
Definition
Asthma/COPD; Methylxantine |
|
|
Term
|
Definition
Asthma/COPD; Methylxantine |
|
|
Term
|
Definition
Asthma/COPD; Methylxantine |
|
|
Term
|
Definition
Asthma/COPD; Methylxantine (theophylline preparation) |
|
|
Term
|
Definition
Asthma/COPD; Methylxantine (theophylline preparation) |
|
|
Term
|
Definition
Asthma/COPD; PDE4 inhibitor (oral); increases cAMP levels reducing activities of immune cells; contraindicated in hepatic impairment |
|
|
Term
|
Definition
Asthma/COPD; IV Muscarinic Receptor Antagonist (competitve) |
|
|
Term
|
Definition
Asthma/COPD; Inhaled Muscarinic Receptor Antagonist (competitve) |
|
|
Term
|
Definition
Asthma/COPD; Anti-IgE monoclonal antibody that blocks portion of IgE that binds to mast and other inflammatory cells; also reduces receptor numbers |
|
|
Term
|
Definition
Not used in asthma; bronchodilator |
|
|
Term
|
Definition
rarely used in asthma; longer-acting broncodilator |
|
|
Term
|
Definition
rarely used in asthma; bronchodilator and expectorant |
|
|
Term
Oxymetazoline, Xylometazoline, Tetrahydrozoline, Naphazoline |
|
Definition
|
|
Term
Phenylephrine, Pseudoephedrine |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
Eicosanoid; PGE2 analog; cervical ripeining and abortion (vaginal suppository) |
|
|
Term
|
Definition
Eicosanoid; PGF2α analog; Abortion |
|
|
Term
|
Definition
Eicosanoid; PGE1 analog; Mucosal protective agent for NSAID induced gastric ulcers |
|
|
Term
|
Definition
Eicosanoid; PGE1 analog; Erectile dysfunction and to maintain ductus arteriosus in newborns until surgical closure |
|
|
Term
|
Definition
Eicosanoid; IV PGI2 analog; Severe Pulmonary Arterial Hypertension (PAH) |
|
|
Term
|
Definition
Eicosanoid; Inhaled PGI2 analog; Severe Pulmonary Arterial Hypertension (PAH) |
|
|
Term
|
Definition
Eicosanoid; IV/SC/Inhaled PGI2 analog; Severe Pulmonary Arterial Hypertension (PAH) |
|
|
Term
|
Definition
PGF2α analog; Open-angle glaucoma eye drop |
|
|
Term
|
Definition
PGF2α analog; Open-angle glaucoma eye drop and enhances eyelash growth as a topical |
|
|
Term
|
Definition
NSAID (Oral and Suppository); antiplatelet |
|
|
Term
|
Definition
NSAID (Oral and Eye Drop) |
|
|
Term
|
Definition
|
|
Term
|
Definition
NSAID (Oral, IV, Suppository) |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
Fenoprofen, Flurbiprofen, Ibuprofen, Ketaprofen |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
NSAID (Oral, IV, Eye Drop) |
|
|
Term
|
Definition
|
|
Term
|
Definition
Anti-inflammatory; Acute and prophylactic gout treatment |
|
|
Term
|
Definition
Uricosuric; prophylactic gout therapy; also sometimes given with chosen beta-lactam antibiotics because it increases their plasma levels by competitively inhibiting their renal tubular secretion |
|
|
Term
|
Definition
Uricosuric; prophylactic gout therapy |
|
|
Term
|
Definition
Xanthanine Oxidase Inhibitor; prophylactic gout therapy |
|
|
Term
|
Definition
Xanthanine Oxidase Inhibitor; prophylactic gout therapy |
|
|
Term
Aluminum Hydroxide (also a combo drug with Magnesium Hydroxide) |
|
Definition
|
|
Term
Calcium Carbonate, Sodium Bicarbonate |
|
Definition
|
|
Term
|
Definition
|
|
Term
Cimetidine, Ranitidine, Famotidine |
|
Definition
H2-Receptor Blocker; GERD and Peptic Ulcer Disease (Oral/IV) |
|
|
Term
|
Definition
H2-Receptor Blocker; GERD and Peptic Ulcer Disease (Oral Only) |
|
|
Term
Omeprazole, Lansoprazole, Rabeprazole |
|
Definition
Proton Pump Inhibitor (PPI); Gerd and Peptic Ulcer Disease (Oral Only) |
|
|
Term
Pantoprazole, Esomeprazole |
|
Definition
Proton Pump Inhibitor (PPI); Gerd and Peptic Ulcer Disease (Oral/IV) |
|
|
Term
|
Definition
Mucosal Protective Agent; Duodenal Ulcers |
|
|
Term
|
Definition
Mucosal Protective Agent; Indigestion, ulcer caused by H.Pylori, and nonspecific diarrhea |
|
|
Term
|
Definition
D2 Receptor Antagonist; Gastric paresis, delayed gastric emptying |
|
|
Term
|
Definition
Acetylcholinesterae (ACh) Inhibitor (IV); Acute colonic pseudo-obstruction in hospitalized patients |
|
|
Term
|
Definition
Bulk forming laxative (oral); safest most natural, usually for chronic constipation |
|
|
Term
|
Definition
Bulk forming laxative (oral); safest most natural, usually for chronic constipation |
|
|
Term
|
Definition
Bulk forming laxative (oral); safest most natural, usually for chronic constipation |
|
|
Term
|
Definition
Bulk forming laxative (oral); safest most natural, usually for chronic constipation |
|
|
Term
|
Definition
Stool Surfactants (Softeners); oral and rectal; for patients who should avoid straining during defecation |
|
|
Term
|
Definition
Lubricant Laxative; Oral and Rectal; temporary relief of occasional constipation |
|
|
Term
|
Definition
Antacid and Saline Osmotic Laxative; acute constipation |
|
|
Term
Magnesium Citrate, Magnesium Sulfate |
|
Definition
Saline Osmotic Laxative; acute constipation |
|
|
Term
|
Definition
Saline Osmotic Laxative; acute constipation |
|
|
Term
|
Definition
Non-saline Osmotic Laxative; Rectal; acute constipation |
|
|
Term
|
Definition
Non-saline Osmotic Laxative; Oral and Rectal; acute constipation |
|
|
Term
|
Definition
Non-saline Osmotic Laxative; acute constipation |
|
|
Term
|
Definition
Stimulant Laxative; short-term treatment of constipation and for evacuation of the colon for bowel or rectal exams |
|
|
Term
|
Definition
Stimulant Laxative; Oral and Rectal; short-term treatment of constipation and for evacuation of the colon for bowel or rectal exams |
|
|
Term
|
Definition
Laxative; Chloride Channel Activator; chronic idiopathic constipation and constipation-predominant IBS in women |
|
|
Term
|
Definition
Laxative; Opioid Receptor Antagonist (SubQ); Opioid-induced constipation |
|
|
Term
|
Definition
Laxative; Opioid Receptor Antagonist; Postoperative ileus to accelerate upper and lower GI recovery following partial large or small bowel resection surgery |
|
|
Term
|
Definition
Antidiarrheal; Opioid agonist; Mild to moderate acute diarrhea and chronic diarrhea due to IBS of IBD; Does not cross BBB |
|
|
Term
Diphenoxylate (w/ atropine) |
|
Definition
Antidiarrheal; Opioid agonist; Mild to moderate acute diarrhea and chronic diarrhea due to IBS of IBD; Crosses BBB |
|
|
Term
|
Definition
Antidiarrheal agent (SubQ/IV); GI neuroendocrine tumor-associated diarrhea |
|
|
Term
|
Definition
Antispasmodic; Anticholinergic antispasmodic; acute spasmodic attacks due to IBS |
|
|
Term
|
Definition
Serotonin (5-HT3) receptor antagonist; severe diarrhea-predominant IBS in women non-responsive to conventional therapy |
|
|
Term
Mesalamine (5-ASA), Sulfasalazine, Balsalazide, Olsalazine |
|
Definition
Aminosalicylates; Mild to moderate ulcerative colitis (IBD) |
|
|
Term
Ondansetron, Granisetron, Dolasetron, Palonosetron |
|
Definition
Serotonin (5-HT3) receptor antagonists (Oral/IV); antiemetic agents for chemotherapy-induced nausea and vomiting and for postoperative/postradiation N/V |
|
|
Term
|
Definition
Neurokinin 1 (NK1) receptor antagonist; Oral Antiemtic agents for prevention of N/V in patients receiving chemotherapy; given with 5-HT3 antagonists |
|
|
Term
|
Definition
Neurokinin 1 (NK1) receptor antagonist; IV Antiemtic agents for prevention of N/V in patients receiving chemotherapy; given with 5-HT3 antagonists |
|
|
Term
Dexamethasone, Methylprednisolone |
|
Definition
Corticosteroids (Oral/IV); Antiemtic agents for prevention of N/V in patients receiving chemotherapy; given with 5-HT3 antagonists |
|
|
Term
|
Definition
D2 Receptor Antagonists (Oral/IV); Antiemtic agents for postoperative N/V |
|
|
Term
|
Definition
D2 Receptor Antagonists (IV/IM); Antiemtic agents for postoperative N/V |
|
|
Term
|
Definition
D2 Receptor Antagonists (Oral/IV); Antiemtic agents for postoperative N/V |
|
|
Term
|
Definition
D2 Receptor Antagonists (Oral/IV); Antiemtic agents for postoperative N/V |
|
|
Term
|
Definition
1st Generation Antihistamine; H1 Receptor Antagonist; Antiemetic agent for prevention and treatment of N/V, vertigo associated with motion sickness; Symptomatic relief of allergic rhinitis and urticaria |
|
|
Term
|
Definition
1st Generation Antihistamine; H1 Receptor Antagonist (Oral/IV); Antiemetic agent for prevention and treatment of N/V, vertigo associated with motion sickness; Symptomatic relief of allergic rhinitis and urticaria |
|
|
Term
|
Definition
Muscarinic Receptor Antagonist (Oral/Transdermal Patch); Antiemetic agent for prevention and treatment of N/V, vertigo associated with motion sickness |
|
|
Term
|
Definition
Cannabinoids; Antiemetic agents for chemotherapy induced N/V |
|
|
Term
|
Definition
Pancreatic Enzyme Supplement; pancreatic insufficiency due to cystic fibrosis, chronic pancreatitis, pancreatic resection |
|
|
Term
|
Definition
Bile Acid Therapy; gallstones in patients with symptomatic gallbladder disease |
|
|
Term
|
Definition
1st Generation Antihistamine; Symptomatic relief of allergic rhinitis and urticaria |
|
|
Term
|
Definition
1st Generation Antihistamine; Symptomatic relief of allergic rhinitis and urticaria |
|
|
Term
|
Definition
1st Generation Antihistamine; Symptomatic relief of allergic rhinitis and urticaria; OTC cough suppressant |
|
|
Term
|
Definition
1st Generation Antihistamine; Symptomatic relief of allergic rhinitis and urticaria |
|
|
Term
Brompheniramine, Chlorpheniramine |
|
Definition
1st Generation Antihistamine; Symptomatic relief of allergic rhinitis and urticaria |
|
|
Term
|
Definition
1st Generation Antihistamine; Symptomatic relief of allergic rhinitis and urticaria |
|
|
Term
|
Definition
2nd Generation Antihistamine; Symptomatic relief of allergic rhinitis and urticaria |
|
|
Term
|
Definition
2nd Generation Antihistamine; Symptomatic relief of allergic rhinitis and urticaria |
|
|
Term
|
Definition
"3rd" Generation Antihistamine; Symptomatic relief of allergic rhinitis and urticaria |
|
|
Term
|
Definition
"3rd" Generation Antihistamine; Symptomatic relief of allergic rhinitis and urticaria |
|
|
Term
|
Definition
"3rd" Generation Antihistamine; Symptomatic relief of allergic rhinitis and urticaria |
|
|
Term
|
Definition
Selective Serotonin Receptor Agonists (Oral/Nasal/SubQ); Severe migraines, cluster headaches **not for prophylaxis b/c of ADRs |
|
|
Term
|
Definition
Selective Serotonin Receptor Agonists (Oral/Nasal); Severe migraines, cluster headaches **not for prophylaxis b/c of ADRs |
|
|
Term
Almotriptan, Eletriptan, Frovatriptan, Rizatriptan, Naratriptan |
|
Definition
Selective Serotonin Receptor Agonists (ORAL); Severe migraines, cluster headaches **not for prophylaxis b/c of ADRs |
|
|
Term
Triple Antibiotic Ointment |
|
Definition
Bacitracin, Neomycin, Polymixin B; topical antibacterial agent |
|
|
Term
|
Definition
Topical antibacterial agent; works against gram +/- bacteria |
|
|
Term
|
Definition
Topical antibacterial agent; works against gram +/- bacteria |
|
|
Term
|
Definition
Topical antibacterial agent; works against MRSA, gram + bacteria, and some anaerobic gram - bacteria |
|
|
Term
|
Definition
Topical antibacterial agent; works against gram - bacteria |
|
|
Term
|
Definition
Topical antibacterial agent; works against gram - bacteria; usually in combination ointments and the most frequent cause of skin reactions |
|
|
Term
|
Definition
Topical antibacterial agent; works against gram - bacteria |
|
|
Term
|
Definition
Topical antibacterial agent; acne vulgaris |
|
|
Term
|
Definition
Topical antibacterial agent; acne vulgaris |
|
|
Term
|
Definition
Topical antibacterial agent; acne vulgaris |
|
|
Term
|
Definition
Topical antibacterial agent; acne vulgaris |
|
|
Term
|
Definition
Topical antibacterial agent; works against gram + cocci; safe for pediatric use |
|
|
Term
|
Definition
Topical antifungal agent; often combined with a corticosteroid |
|
|
Term
|
Definition
Topical antifungal agent; also available as a shampoo for seborrheic dermatitis |
|
|
Term
|
Definition
Agent used to treat malathion poisoning |
|
|
Term
|
Definition
Ectoparasiticide; Organophosphate cholinesterase inhibitor; head and pubic lice |
|
|
Term
|
Definition
Ectoparasiticides; last resort agent for head and pubic lice |
|
|
Term
|
Definition
Given to replenish the body's GSH stores and prevent hepatotoxicity in the event of an APAP overdose |
|
|
Term
|
Definition
Absorbs APAP in the GI in the event of an overdose |
|
|
Term
|
Definition
Laxative for preparation of bowel for examination or surgery |
|
|